Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BAALC antisense RNA 2 (BAALC-AS2) is a long non-coding RNA gene located on chromosome 8, also known by aliases such as BAALCOS and C8orf56. It is expressed in multiple tissues, including brain, heart, and liver, and is involved in the regulation of gene expression, cell proliferation, differentiation, and apoptosis. Functionally, BAALC-AS2 can act as a sponge for microRNAs, preventing them from binding to their target mRNAs, thereby changing the expression of genes critical for cellular processes. Recent research links BAALC-AS2 to the promotion of cancer cell proliferation and migration, especially by enhancing c-Myc expression through a feedback loop with G3BP2, implicating it as a regulator in tumor progression, especially in esophageal squamous cell carcinoma. However, it is not a classical drug target, and as of now, there are no approved drugs directly targeting it. Elevated BAALC-AS2 expression may be a candidate diagnostic or prognostic biomarker for certain cancers.
BAALC-AS2 acts as a microRNA sponge, disrupting microRNA-target interactions and regulating target gene expression, such as oncogenic pathways involving c-Myc and G3BP2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BAALC antisense RNA 2 (BAALC-AS2).